戻る Agenda
Session 4: Clinical Trial Diversity and Inclusion: Perspectives from FDA, Industry, and Clinical Research Sites
Session Chair(s)
Richardae Araojo, PHARMD, MS
Associate Commissioner for Minority Health, Director, Office of Minority Health
FDA, United States
Join leaders from the FDA’s Office of Minority Health and Health Equity, the FDA’s Office of Women’s Health, alongside representatives from industry and clinical research sites for a thought-provoking session that explores strategies that work towards enhancing the diversity of clinical trial populations.
Learning Objective : - Describe FDA efforts to advance the inclusion of minorities and women in clinical trials
- Identify industry efforts that support clinical trial diversity
- Contribute to internal discussions to manage the challenges of enhancing diversity in clinical trials
- Explain clinical research site activities that advance clinical trial diversity through community engagement
Speaker(s)
Speaker
Kaveeta Vasisht, DrMed, MD, PHARMD
FDA, United States
Associate Commissioner for Women's Health, Director of the Office of Women’s Hea
Speaker
Cassandra Smith, MBA
Janssen Research & Development, United States
Director, Diversity, Equity, and Inclusion in Clinical Trials
Speaker
Fabian Sandoval, MD
ECRI, United States
President and Chief Executive Officer